While most drugs are administered orally, there are numerous advantages to the percutaneous route. These advantages include the potential for sustained release, controlled input kinetics, improved patient compliance, and avoidance of first-pass metabolism in the gastrointestinal tract. However, the stratum corneum (SC), the outermost layer of the epidermis, is the principal rate limitation to percutaneous absorption. The SC layer is composed of keratin-enriched corneocytes embedded in a multilamellar lipid matrix, which mainly comprises ceramides, cholesterol and free fatty acids.
While most drugs are administered orally, there are numerous advantages to the percutaneous route. These advantages include the potential for sustained release, controlled input kinetics, improved patient compliance, and avoidance of first-pass metabolism in the gastrointestinal tract. However, the stratum corneum (SC), the outermost layer of the epidermis, is the principal rate limitation to percutaneous absorption. The SC layer is composed of keratin-enriched corneocytes embedded in a multilamellar lipid matrix, which mainly comprises ceramides, cholesterol and free fatty acids. 1, 2) Both physical methods (SC stripping, iontophoresis, phonophoresis and microneedle) and chemical methods (synthesis of lipophilic analogues and skin permeation enhancers) are used to promote the delivery of drugs across the skin. Of these methods, the most widely implemented approach to increase percutaneous absorption is the use of skin permeation enhancers, which ideally cause a temporary, reversible reduction in the barrier function of the SC in order to facilitate safe and effective drug delivery through the skin. 3) In theory, there are two potential pathways through the SC: the transcellular pathway, which involves permeation across the corneocytes and multilamellar lipid matrix, and the intercellular pathway, which involves permeation via the lipid domains between the corneocytes. Within the corneocytes, the major site of action would be the keratin fibrils and their associated water molecules. 4) Within the intercellular route, it is proposed that enhancers may interact with the polar head groups and between the hydrophobic tails of the lipid bilayers. The lipid matrix of the SC, therefore, is a target of action for permeation enhancers. 5) Considering the structure of the SC and the continuity of the lipid barrier, interaction with SC intercellular lipids is of crucial importance for the effectiveness of permeation enhancers. 5) Pentazocine (PTZ, M w : 285.42, log P: 3.08 (pH 7.0)), a benzomorphan derivative, is an opioid analgesic that has mixed opioid agonist-antagonist function. It is considered to be a partial agonist or weak antagonist at the m-receptor and an agonist at the k-receptor. PTZ is used for the relief of moderate to severe pain. Oral administration of PTZ has the disadvantage of low bioavailability (approximately 20%) due to extensive first-pass metabolism. In addition, PTZ has a short half-life of 2-3 h and requires frequent dosing in order to maintain an optimal therapeutic concentration. There is a clinical need for PTZ to be made available as a long-acting formulation for chronic pain management. 6) We have already reported the effects of glyceryl monocaprylate (GEFA-C 8 ) as an enhancer of the permeation of PTZ in isopropyl myristate (IPM) solution across excised hairless mouse skin. We found that the flux of PTZ combined with both GEFA-C 8 and IPM was approximately 4 times higher than that with IPM alone. 7) Moreover, we demonstrated that a novel transdermal drug delivery system patch composed of Duro-Tak ® 87-9301 adhesive polymer, IPM and GEFA-C 8 (as skin permeation enhancers) could incorporate up to 30% PTZ without crystal formation with a maximum flux of 24.2 mg/cm 2 /h. 8) However, it remained unclear whether the combination of IPM and GEFA-C 8 affected the SC resulting in enhancement of skin permeation of PTZ.
Although synergistic effects of skin permeation enhancers in transdermal drug delivery have been well documented, 9) the mechanisms responsible for such synergies remain largely unknown. Understanding the mechanism of action of percutaneous enhancers at the molecular level is important in their judicious inclusion in transdermal formulations to enhance the permeation of drugs across the skin so as to achieve therapeutically effective blood concentrations. In this study, the mode of action of the IPM/GEFA-C 8 system was elucidated in detail using attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR), small angle Xray diffraction (SAXD) and confocal laser scanning mi- croscopy (CLSM). The ATR-FTIR and SAXD measurements allowed us to probe the intercellular lipid domain of the SC to provide information specifically on lipid fluidization and arrangement. CLSM was employed to visually characterize the barrier properties of hairless mouse skin by investigating the penetration pathways of a model compound across its SC. Using these tools, this is the first study to investigate the mechanism of skin permeability enhancement via the synergistic effects of IPM and GEFA-C 8 .
MATERIALS AND METHODS
Materials PTZ was purchased from Kobayashi Kako Co., Ltd. (Fukui, Japan). Isopropyl myristate (IPM) was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Glyceryl monocaprylate (GEFA-C 8 , Sunsoft ® 700P-2) was gifted by Taiyo Kagaku Co., Ltd. (Mie, Japan). Trypsin (type II-S) and 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethyl-indocarbocyanine perchlorate (DiI) were purchased from Sigma Aldrich (St. Louis, MO, U.S.A.). All other solvents and reagents were commercial products of analytical grade and were used without further purification.
Determination of Drug Solubility To determine the saturation solubility of PTZ in IPM with/without each concentration of GEFA-C 8 , excess PTZ was added to known volumes of IPM with/without each concentration of GEFA-C 8 , vortexed for 30 s followed by sonication for 20 min to dissolve the PTZ and then equilibrated at 32°C for 24 h. Finally, the suspension was filtered through a membrane filter (0.45 mm) and aliquots of the filtered saturated solution were diluted and analyzed by high performance liquid chromatography (HPLC).
Skin Permeation Studies All animal experiments were carried out in accordance with the guidelines of the Institutional Animal Care and Use Committee (College of Pharmacy, Nihon University, Chiba, Japan). The full-thickness dorsal skin of male Hos:HR-1 hairless mice (5-10 weeks, Hoshino Laboratory Animals, Inc., Ibaragi, Japan), sacrificed by ether, was excised and adherent fat and other visceral debris were removed from the undersurface. In vitro permeation studies were carried out with a Franz diffusion cell (Vertical diffusion cell TM , Hanson Research Corporation, CA, U.S.A.) at 32°C. Saturated PTZ solution (200 ml) in IPM with or without various concentrations of GEFA-C 8 was added to the donor cell. Saturated solutions were used for the diffusion experiments for maximal thermodynamic activity of the drug.
10) The effective area of diffusion was 1.77 cm 2 , and the receiver cell volume was approximately 7 ml. The receiver cell was filled with phosphate buffered saline (PBS) (pH 7.4) and stirred at 650 rpm using a magnetic stirrer. The amount of PTZ that permeated the receiver cell was quantitated by collecting 0.5 ml of samples at the designated time intervals, and analyzing these by HPLC. The volume of receiver cell fluid withdrawn at each interval was replaced with PBS.
Analytical Method The HPLC system was constructed with a PU-2080 plus intelligent HPLC pump, a UV-2075 intelligent UV/VIS detector, and an AS-2055 plus intelligent sampler (all from JASCO Co., Tokyo, Japan). The analytical column, CAPCELL PAK C18, type MG (150 mmϫ4.6 mm i.d.; particle size 5 mm; Shiseido Co., Ltd., Tokyo, Japan) was used at room temperature. The mobile phase consisted of 0.05 M phosphoric acid and acetonitrile (77 : 23, v/v) at a flow rate of 1.0 ml/min. The column eluate was monitored using an ultraviolet wavelength of 278 nm.
Data Analysis The cumulative amount of drug permeating through the skin was plotted as a function of time. The skin flux was determined using Fick's law of diffusion:
where J ss is the steady-state skin flux in mg/cm 2 /h, dQ r is the change in quantity of the drug passing through the skin into the receptor compartment in mg, A is the active diffusion area in cm 2 , and dt is the change in time. The flux was calculated from the slope of the linear portion of the profiles. The permeability coefficient (P) was calculated using 11) :
PϭJ ss /C s where C s is the saturation solubility of the drug in the donor solution.
To evaluate the promoting activity of each concentration of GEFA-C 8 in IPM, an enhancing ratio (ER) was defined as follows: ERϭP (each concentration of GEFA-C 8 )/P (IPM only).
12)

ATR-FTIR Spectroscopic Studies
The hairless mouse skin prepared as described above was soaked in IPM with or without 10% w/w GEFA-C 8 at 32°C for 24 h. The treated skin samples were washed with PBS and blotted dry. The infrared spectra of skin samples were obtained using Fourier transform infrared spectroscopy (FTIR-230 spectrometer, JASCO Co.) with an attenuated total reflection (ATR) unit (ATR-500/M, JASCO Co.). The unit was modified for heating of the ATR mount from 25 to 70°C with an integrated heater and a temperature controller (T-550-P, Iuchi, Osaka, Japan). The spectrum recorded represents an average of 32 scans obtained with a resolution of 2 cm Ϫ1 at room temperature. The spectra were collected in the wavenumber range of 4000-400 cm Ϫ1 . The internal reflectance element (IRE) used in this study was a zinc selenide trapezoid having 45°e ntrance and exit faces. Skin was carefully mounted on the IRE. Preparation of SC Samples SC was separated from hairless mouse skin by digestion with 0.1% w/v trypsin in PBS solution (pH 7.4) at 32°C for 12 h. The SC was then rinsed in distilled water and dried under vacuum using a rotary pump. Dry SC was soaked in IPM or IPM/GEFA-C 8 (10% w/w) solution at 32°C for 2 h. The treated SC was carefully wiped using a kimwipe and then dried under vacuum using a rotary pump for 12 h. Before use, the SC was hydrated to give a water content varying between 30-40% w/w. Water content is defined as: [(weight hydrated SCϪ weight dry SC)/weight hydrated SC]ϫ100. Untreated SC samples served as controls.
Small Angle X-Ray Diffraction Measurement SAXD measurements on treated SC samples were performed on a NanoSTAR instrument (Bruker AXS, WI, U.S.A.) with a CuK a radiation source operating at 45 kV/120 mA. The wavelength (l) of the X-ray beam was 0.155 nm. The sample SC (approximately 10 mg) was held in an aluminum sample holder, which was sealed with Kapron films on both sides. The sample to detector distance was set to 106 cm.
Localization of Hydrophobic Fluorescence Probe (DiI) in the Skin This procedure was carried out in a similar manner as reported previously. 13) The procedure was the same as for the regular skin permeation study described above. Briefly, 200 ml of DiI (0.5 mg/ml) solution in IPM with or without 10% w/w GEFA-C 8 was added to the donor cell. Dimethyl sulfoxide (1% of total volume of solution) was used to dissolve DiI in the donor solution. The receiver cell was filled with PBS. The skin was fixed with 20% formalin neutral buffer solution 12 h after the application of donor solution containing the fluorescein probe. Next, the surface of the skin was observed using CLSM (LSM 510, Carl Zeiss Co., Ltd., Tokyo, Japan). All samples were excited at 488 and 543 nm and X-Z sectioning was used to determine the depth of permeation using an ϫ40 objective lens. The skin surface (Zϭ0 mm) is defined by user as the brightest fluorescence image with a morphology characteristics of the SC surface.
14)
Statistical Analysis The results were analyzed by oneway analysis of variance (ANOVA), followed by the modified Fisher's least-squares difference method. The level of statistical significance was set at pϽ0.05.
RESULTS AND DISCUSSION
Effect of the Concentration of GEFA-C 8 with IPM on Skin Permeation of PTZ The permeation of PTZ through excised hairless mouse skin treated with IPM combined with various concentrations of GEFA-C 8 was examined. Table 1 shows the skin permeation parameters of PTZ. Figure 1 shows the effect of the concentration of GEFA-C 8 on the P value of PTZ. The P value of PTZ increased linearly with increasing concentrations of GEFA-C 8 from 0 to 10% w/w in IPM solution; however, the P value started to decrease again at a concentration of GEFA-C 8 of 12.5% w/w. Therefore, the most effective enhancing concentration of GEFA-C 8 was determined to be 10% w/w, because it was considered that solubility of PTZ at a concentration of GEFA-C 8 of 10% w/w in IPM solution would be saturated as shown in Table 1 . For the following experiments, 10% w/w GEFA-C 8 was used.
ATR-FTIR Studies ATR-FTIR spectroscopy can provide structural information localized in a surface layer of limited thickness and is thus applicable to in vivo and ex vivo studies of full-thickness skin. The ATR-FTIR stretching peaks at 2851.2 cm Ϫ1 (C-H symmetric stretching absorbance frequency peak) and 2920.3 cm Ϫ1 (CH 2 asymmetric stretching absorbance frequency peak), were measured before and after the application of IPM or a combination of IPM/GEFA-C 8 to hairless mouse skin (Figs. 2A, B) . The frequencies of these bands are sensitive to the trans/gauche ratio of the alkyl tails. The CH 2 asymmetric and symmetric stretching bands near 2920 and 2850 cm
Ϫ1
, respectively, are due to the methylene groups of the SC lipid alkyl chains.
15) The magnitude of the blue shift in the peak frequency of the asymmetric and symmetric stretching vibration absorbance has been correlated with an increased number of gauche conformers in the lipid acyl chain (a process called rotamer disordering). 15, 16) The higher the shifts were, the higher the ratio of gauche to trans. It has been demonstrated that promoters causing a higher shift in CH 2 stretching frequency improve drug permeation. In comparison to peaks near 2920.3 and 2851.2 cm Ϫ1 for asymmetric and symmetric stretching, respectively, in untreated skin, treatment of skin with IPM resulted in a shift to frequencies which were significantly higher by approximately 3 and 2 cm Ϫ1 , respectively. These blue shifts in CH 2 stretching frequency have been attributed to the so-called disordering of the lipids, which refers to an increase in motional freedom of the lipid alkyl chains. 15, 16) Panchagnula et al. reported that CH 2 symmetric and asymmetric stretching bands of IPM-treated skin shifted towards a higher wavenumber than untreated skin. 17, 18) Therefore, our present results were consistent with previous findings. Moreover, in skin treated with a combination of IPM and GEFA-C 8 , higher frequency shifts in CH 2 symmetric and asymmetric stretching were observed than with IPM alone. This increased lipid fluidity after combination of IPM and GEFA-C 8 treatment was responsible for the enhanced permeability of PTZ through hairless mouse skin. We suggest that the molecular basis of these permeability changes is lipid disruption. Figures 3A and B show the effect of temperature on the CH 2 stretching frequencies of hairless mouse skin treated with IPM or IPM/GEFA-C 8 . In untreated skin, the CH 2 asymmetric and symmetric stretching bands shifted from 2919.7 to 2923.6 cm Ϫ1 and from 2851.2 to 2853.2 cm
, respectively, following an increase in temperature from 25 to 70°C. Golden et al. reported that the CH 2 symmetric and asymmetric stretching frequencies in porcine SC also shift to a higher wavenumber upon heating. 19) They suggested that thermally induced increases in the wavenumber of CH 2 absorbance are due to increased motional freedom and numbers of gauche conformers of lipid alkyl chains undergoing thermal phase transition. 20) Moreover, Boncheva et al. reported thermotropic changes to the position of the CH 2 symmetric stretching mode, which reflects the conformational order of the lipid chains. 21) They compared the temperature dependence of the position of the CH 2 symmetric stretching mode in spectra collected while heating human SC from 28 to 90°C. The orthorhombic (OR)-hexagonal (HEX) phase transition was observed in the temperature range from 28-50°C (midpoint at 37.0Ϯ0.4°C); this resulted in a small increase in the CH 2 symmetric stretching frequency. 22) Upon further increase in temperature, they also observed the HEX-liquidcrystalline (LIQ) phase transition (midpoint at 75.0Ϯ0.2°C), which resulted in a large increase in the CH 2 symmetric stretching frequency.
23) The existence of lipids in ordered (OR and HEX) and disordered (LIQ) phases has been demonstrated in isolated SC and in model mixtures of SC lipids (i.e., ceramides, free fatty acids, and cholesterol). We found that when skin was treated with IPM, the blue shift in both asymmetric and symmetric stretching frequencies was increased from 2922.9 to 2924.5 cm Ϫ1 and from 2853.2 to 2854.5 cm
, respectively, with increasing temperature.
Comparing untreated skin with IPM-treated skin, the addition of IPM to hairless mouse skin did not clearly change the shape of the wavenumber-temperature profile; the asymmetric and symmetric stretching frequencies at 25°C (2922.9, 2853, respectively) were the same as those of untreated skin at higher temperatures (2922.6 at 60°C and 2853.2 at 70°C, respectively). Similar spectral changes have been observed by other authors for model SC lipids treated with 1,8-cineole and l-menthol. 24) They reported a significant blue shift in both CH 2 symmetric and asymmetric stretching frequencies of lipids in a model SC lipid mixture when 1,8-cineole and lmenthol were incorporated into it. This indicates that these compounds increase disorderliness of the lipid alkyl chains at low temperatures including physiological temperature. We found that CH 2 stretching frequency values for skin treated with IPM were higher throughout the thermal profile, indicating a higher degree of lipid fluidization in the lipid alkyl chain. In addition, when SC was treated with IPM/GEFA-C 8 , both symmetric and asymmetric stretching frequencies were shifted to a higher wavenumber than in the presence of IPM alone at 25°C. Moreover, the thermal profile showed a higher wavenumber throughout with IPM/GEFA-C 8 treatment than with IPM treatment alone, with wavenumber remaining fairly constant above 40°C. Therefore, in the presence of the combination of IPM and GEFA-C 8 , the SC lipid alkyl chain was not affected by increasing temperature, indicating a conformational change to all-gauche lipid chain or disordered (LIQ) phase.
The bands near 1650 and 1550 cm Ϫ1 are due to the amide I and II stretching frequencies of SC protein, respectively. The amide I band arises from CϭO stretching frequency and the amide II from C-N stretching and N-H bending frequency. The frequencies of these two bands, especially the amide I band, are sensitive and shift to higher or lower frequencies according to changes in SC protein conformation. 25) The wavenumber of these characteristic spectral peaks is shown in Figs. 4A and B as treated with IPM and IPM/GEFA-C 8 , respectively. IR spectra of hairless mouse skin treated with IPM with or without GEFA-C 8 revealed no significant shift in the amide I and II bands, suggesting that there was no change in protein conformation in the SC. When considered in the context of skin permeability data (Fig. 1, Table 1) , this analysis shows that increased transdermal flux correlates with increased SC lipid disorderliness and not altered SC protein conformation caused by exposure to the combination of IPM and GEFA-C 8 .
SAXD Studies To elucidate the mechanisms involved in transdermal drug delivery, an understanding of the structure of the intercellular lipid matrix of the SC is essential. Intercellular lipids form multilamellar structures, which have been observed by X-ray diffraction 26, 27) and electron microscopy. 28) In this part of our investigation, we studied the effect of IPM and IPM/GEFA-C 8 on the multilamellar structures of SC lipids by SAXD. The multilamellar structures in the SC are classified mainly into long and short lamellar structures with repeat distances of approximately 13 and 6 nm, respectively. 29) Firstly, we carried out SAXD measurements on hairless mouse SC with a water content of 0% w/w. A diffraction peak position for 1st to 4th order diffraction of approximately 14 nm was observed in untreated SC; however all diffraction peaks were completely eliminated by pretreatment with IPM and IPM/GEFA-C 8 . It is reported that with increased water content up to approximately 30%, the diffraction peak positions for long lamellar structures are almost unchanged, although the sharpness of these peaks depends on water content. 30) Therefore, for the following experiments, SAXD measurements were carried out on samples with a water content of approximately 30-40% w/w. Diffraction peaks of short lamellar structures at approximately 6 nm were never observed in samples with this increased water content. Ohta et al. reported that the short lamellar spacing of hairless mouse skin increased from 5.8 to 6.6 nm with increasing water content and became sharp from 12 to 50% w/w. 30) While most studies of SC lamellar lipids have used synchrotron X-ray diffraction, 27) we used conventional SAXD equipment. The luminance of synchrotron radiation is 10 6 -10 9 times stronger than conventional radiation. Short lamellar peak intensities around 6 nm are very weak, therefore we were unable to observe these peaks using conventional X-ray diffraction.
SAXD measurement of untreated SC hydrated to approximately 30% w/w revealed the 1st to 4th order diffraction of approximately 14 nm lamellar spacing (dϭ14, 6.7, 4.5, 3.3 nm from 1st to 4th order diffraction, respectively) (Fig.  5A ). This is in close accordance with results from synchrotron X-ray diffraction published by other authors. 30, 31) In contrast, the diffraction peak (approximately 5.7 nm) of SC prepared using IPM was broad and very weak in intensity (Fig.  5B) . This suggests that IPM may cause disorder of the stacking arrangement of the lipid bilayers. Moreover, SAXD measurements showed that in SC treated with the combination of IPM and GEFA-C 8, all peaks disappeared entirely. This suggests that the combination of IPM and GEFA-C 8 affected the long distance bilayer packing strength, resulting in a complete loss of order of SC lipid bilayers (Fig. 5C ). Taking together the results from ATR-FTIR and SAXD measurements, IPM alone may have partitioned into the SC lipid domain, resulting in fluidization and disorder of SC lipids. On the other hand, GEFA-C 8 inserts into SC lipid structures with the aid of IPM, which disrupts the lipid packing.
CLSM Studies The application of fluorescence techniques to the cellular and biomedical aspects of drug delivery Open arrows indicate the 1st to the 4th order diffraction peaks for the long lamellar structure of untreated SC and closed arrow indicates the diffraction peak of IPM-treated SC.
is extensive and has been comprehensively reviewed elsewhere. 32) Furthermore, since CLSM can be used for both confocal and optical sectioning, it is possible to study the cellular/tissue fluorescence localization of fluorescence probes and photosensitizing dyes at a three-dimensional level with very high accuracy. The major advantage of CLSM is that the distribution of the fluorescent model compound in the sample can be visualized without cryo-fixing or embedding the tissue. Recently, in the field of transdermal drug delivery, CLSM has emerged as a powerful tool for determining the mechanisms of diverse skin penetration enhancement strategies. 33) In this study, CLSM was used to clarify the site of action of IPM and IPM/GEFA-C 8 in the SC. The fluorescent probe DiI was chosen as a lipophilic compound, which is one of the long-chain carbocyanine dyes. Attached to the fluorochrome are two long alkyl chains, which determine the affinity of the probe for the membrane. Short-chain carbocyanine dyes are partitioned between the aqueous and membrane phases in a membrane-potential-dependent manner, while long-chain carbocyanine dyes are essentially insoluble in water and become inserted into cells with their alkyl chains embedded in the lipid bilayer. 34) Figure 6 shows confocal images obtained from IPM-and IPM/GEFA-C 8 -treated samples of hairless mouse skin. DiI in IPM solutions both with and without GEFA-C 8 was administered to an in-focus XY plane (parallel to the skin surface) for 24 h. In the case of treatment with DiI in IPM solution, the shape of corneocytes could be distinguished at the surface of the SC. Moreover, DiI was also distributed in the intercellular space of the SC. This suggests that the hydrophobic probe readily distributed in the lipophilic region (intercellular space) of the skin surface. Furthermore, the distribution of DiI was remarkably increased in the intercellular space and around the corneocytes by the addition of GEFA-C 8 to the donor solution compared with treatment with IPM alone. This indicates that GEFA-C 8 enhanced the distribution of DiI to the SC. Moreover, DiI was detected in the deeper skin tissues with the application of GEFA-C 8 . These results suggest that the distribution of hydrophobic probes was increased by the combined application of IPM and GEFA-C 8 .
CONCLUSIONS
This study sought to determine the mechanism by which the combination of IPM and GEFA-C 8 increases percutaneous absorption of PTZ, and found that IPM and GEFA-C 8 synergistically increase skin permeability by disruption of the SC lipid mixture. Using increasing concentrations of GEFA-C 8 in IPM solution from 0 to 12.5% w/w, the highest permeation coefficient was observed at 10% w/w GEFA-C 8 . ATR-FTIR measurements revealed that the combination of IPM and GEFA-C 8 disrupts the multilamellar lipid matrix of hairless mouse skin, but does not change protein conformation. Moreover, SAXD results showed that the combination of IPM and GEFA-C 8 affects the SC lipids, causing the tightly packed intercellular lipid in the SC to become disordered. To corroborate these results, the extent of penetration of DiI, a lipophilic fluorescence probe, was measured by CLSM, in in vitro skin permeation studies using IPM and IPM/GEFA-C 8 as skin permeation enhancers. In the case of either enhancer alone, DiI was distributed into the intercellular space between corneocytes, but the combination of IPM and GEFA-C 8 resulted in increased permeation of DiI which corresponded to more DiI transport across the SC and into the deeper layers of the skin. IPM alone had limited penetration into the skin. We conclude that IPM and GEFA-C 8 act synergistically to increase skin permeability and that this formulation may be useful for transdermal drug delivery applications. 
